Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes

BACKGROUND: Treatment guidelines recommend LDL-C as the primary target of therapy in patients with hypercholesterolemia. Moreover, combination therapies with lipid-lowering drugs that have different mechanisms of action are recommended when it is not possible to attain LDL-C targets with statin mono...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotella, Carlo M, Zaninelli, Augusto, Le Grazie, Cristina, Hanson, Mary E, Gensini, Gian Franco
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918617/
https://www.ncbi.nlm.nih.gov/pubmed/20663203
http://dx.doi.org/10.1186/1476-511X-9-80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918617/
https://www.ncbi.nlm.nih.gov/pubmed/20663203
http://dx.doi.org/10.1186/1476-511X-9-80

Ejemplares similares